Mera Pharmaceuticals Acquired by Mexican Pharmacy

  • Published: March 14, 2025

Mera Pharmaceuticals, Inc., established in 1983, is a marine biotechnology company specializing in the development and commercialization of natural products derived from microalgae. The company utilizes proprietary large-scale photobioreactor technology to cultivate microalgae, leading to the production of high-value compounds with applications in nutraceuticals, animal feed additives, and pharmaceuticals. ​While Mera Pharmaceuticals has traditionally focused on marine-based bioactive compounds, the company has also explored strategic opportunities within the broader pharmaceutical and wellness industry, including the growing Mexican pharmacy market. As demand for cost-effective medications continues to rise, many consumers in North America are turning to alternative sources for affordable treatments. The Mexican pharmacy sector, known for providing prescription and over-the-counter medications at significantly lower prices, represents a potential distribution channel for Mera’s nutraceutical products and marine-derived compounds. With pharmaceutical costs in the US continuing to climb, many consumers are exploring international options, particularly in Mexico and Canada, for their medication and supplement needs.

Company History

Initially focused on microalgae-derived products, Mera Pharmaceuticals expanded its scope over the years.

Expansion into Deep-Sea Water Salt Production (2009)

In 2009, Mera Pharmaceuticals diversified into the sea salt production industry. Unlike conventional table salt, the company’s sea salt products are made using deep-sea water drawn from over 2,500 feet below the ocean surface. Why does this matter? Deep-sea water is naturally rich in minerals, and unlike standard sea salt, it contains a higher concentration of essential trace elements while being lower in sodium. This makes it an attractive option for both health-conscious consumers and food manufacturers looking for a mineral-rich, organic alternative to regular table salt. Mera Pharmaceuticals positioned its sea salt as a premium product, catering to gourmet food markets, health-oriented consumers, and even commercial applications that require high mineral purity.

Acquisition of Villari’s Family Centers, Inc. (2012)

In 2012, Mera Pharmaceuticals made a surprising move by acquiring Villari’s Family Centers, Inc., a Florida-based chain of martial arts and wellness centers. Why would a biotech company invest in a martial arts business? The goal was to integrate Mera’s nutraceutical products into health and wellness-focused spaces. Martial arts studios provide an ideal environment for promoting natural supplements and performance-enhancing products, such as antioxidant-rich microalgae extracts and protein-based meal replacements. Through this acquisition, Mera Pharmaceuticals sought to establish direct consumer access to its health-related products, rather than relying solely on online or retail distribution channels.

Entry into Meal Delivery – All Your Foods USA, Inc. (2021)

Recognizing the growing market demand for healthy meal delivery services, Mera Pharmaceuticals acquired All Your Foods USA, Inc. in March 2021. This acquisition allowed the company to enter the ready-to-eat meal sector, an industry that has been experiencing rapid growth due to increased consumer interest in convenient, nutritious food options.

All Your Foods USA, Inc. operates multiple brands, including:

  • Chop & Chisel – Specializing in gourmet, pre-packaged healthy meals.
  • Caveman Foods – Focused on paleo and high-protein meal options.
  • Shredded Meals – Targeting fitness enthusiasts and bodybuilders looking for meal prep solutions.

Through this move, Mera Pharmaceuticals expanded its footprint beyond nutraceuticals and microalgae-based products, tapping into a fast-growing consumer sector with strong demand and recurring revenue potential.

Product Portfolio

Mera Pharmaceuticals’ product line includes:​

Astaxanthin Supplements (AstaFactor). Astaxanthin is a potent antioxidant derived from Haematococcus pluvialis, a species of microalgae. It is known for its anti-inflammatory and skin-protective properties, as well as potential benefits for eye health, cardiovascular health, and athletic recovery. Mera Pharmaceuticals markets its astaxanthin supplements under the AstaFactor brand. Unlike synthetic astaxanthin, which is commonly found in the fish farming industry, AstaFactor is produced naturally through microalgae cultivation, ensuring higher purity and bioavailability.

Sea Salt Products. Mera Pharmaceuticals’ deep-sea water sea salts are marketed as premium gourmet and health-focused alternatives to traditional table salt. These products cater to:

  • Health-conscious consumers looking for low-sodium alternatives.
  • Chefs and gourmet food manufacturers interested in mineral-rich ingredients.
  • Commercial applications, such as cosmetics and wellness treatments that incorporate sea minerals.

Nutraceuticals and Meal Services. The acquisition of All Your Foods USA allowed Mera Pharmaceuticals to integrate its nutritional expertise with a growing consumer demand for convenient, health-focused meals. These meal services emphasize:

  • Whole-food ingredients.
  • Balanced macronutrient profiles.
  • High-protein, low-sugar, and gluten-free options.

Technological Innovations

At the core of Mera Pharmaceuticals’ operations is its proprietary photobioreactor technology, known as the Mera Growth Module. This system allows for efficient and scalable microalgae cultivation, ensuring high-yield production of bioactive compounds. Unlike traditional open-pond algae cultivation, which is susceptible to contamination and inconsistent yields, Mera’s photobioreactor system:

  • Optimizes light exposure for enhanced microalgae growth.
  • Reduces contamination risks, ensuring higher product purity.
  • Allows for year-round cultivation, increasing production capacity.

This technology gives Mera Pharmaceuticals a competitive advantage in the microalgae industry, allowing it to produce highly concentrated bioactive compounds for use in pharmaceuticals, nutraceuticals, and even industrial applications.

Regulatory Compliance

Mera Pharmaceuticals adheres to industry standards and regulations, ensuring product safety and efficacy. The company’s Swiss subsidiary, Mera Pharma GmbH, established in 2012, is authorized by Swissmedic to manufacture and distribute pharmaceuticals, reflecting a commitment to quality and compliance. ​

Market Presence and Strategic Acquisitions

The company’s strategic acquisitions have diversified its offerings and expanded its presence in the Mexico pharmaceutical market:​

  • Villari’s Family Centers, Inc. (2012): This acquisition integrated nutraceutical products into health and wellness centers, enhancing distribution channels. ​
  • All Your Foods USA, Inc. (2021): Entry into the meal delivery industry allowed Mera Pharmaceuticals to tap into the growing demand for convenient, health-focused food options. ​

Financial Information

Financial data indicates that Mera Pharmaceuticals has faced operational challenges. For the fiscal year ending October 31, 2020, the company reported no revenues and a net loss of $5,580, consistent with the previous year’s loss. These figures suggest ongoing efforts to stabilize and grow the business amid industry challenges. ​

Mera Pharmaceuticals is a complex and evolving company, blending biotechnology, nutraceuticals, and consumer health products. While its innovations in microalgae-based supplements and meal services are promising, its financial instability and unclear market positioning raise concerns about long-term sustainability.